The researchers targeted and regulated KBTBD7 through various measures to inhibit inflammation, cardiac dysfunction, and maladaptive remodeling after myocardial infarction with weak downstream p28 and NF-κB signaling. Here, NFKB1 is linked to myocardial infarction.